1[1]Hall C.Essential biochemistry and physiology of (NTpro)BNP[J].Eur J Heart Fail,2004,6(3):257-260. 被引量：1
2[2]Schellenberger U,O'Rear J,Guzzetta A,et al.The precursor to B-type natriuretic peptide is an O-linked glycoprotein[J].Arch Biochem Biophys,2006,451(2):160-166. 被引量：1
3[3]Shimizu H,Masuta K,Asada H,et al.Characterization of molecular forms of probrain natriuretic peptide in humanplasma[J].Clin Chim Acta,2003,334(1-2):233-239. 被引量：1
4[4]Goetze JP,Kastrup J,Pedersen F,et a1.Quantificationof pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing[J].Clin Chem,2002,48(7):1035-1042. 被引量：1
5[5]Yeo KT,Wu AH,Apple FS,et al.Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay[J].Clin Chim Acta,2003,338(1-2):107-115. 被引量：1
6[6]Chien TI,Chen HH,Kao JT.Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NTproBNP[J].Clin Chim Acta,2006,369(1):95-99. 被引量：1
7[7]Wu AH,Smith A.Biological variation of the natriuretic peptides and their role in monitoring patients with heartfailure[J].Eur J Heart Fail,2004,6(3):355-358. 被引量：1
9[9]Mogelvang R,Goetze JP,Schnohr P,et al.Diseriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide[J].J Am Coll Cardiol,2007,50(17):1694-1701. 被引量：1
10[10]Krauser DG,Chen AA,Tung R,et al.Neither race nor gender influences the usefulness of amino-terminal probrain natriuretic peptide testing in dyspneic subjects:a ProBNP Investigation of Dyspnea in the Emergency Department(PRIDE)substudy[J].J Card Fail,2006,12(6):452-457. 被引量：1
